Cargando…

Safety assessment of glutaminase from Aspergillus niger

Glutaminase (glutamine aminohydrolase EC 3.5.1.2) is used in the production of food ingredients rich in l‐glutamic acid that are added to finished foods for the purpose of enhancing or improving the savory flavor profile of food. The glutaminase enzyme preparation evaluated in these studies, designa...

Descripción completa

Detalles Bibliográficos
Autores principales: Vo, Trung Duc, Sulaiman, Christina, Tafazoli, Shahrzad, Lynch, Barry, Roberts, Ashley, Chikamatsu, Go
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063383/
https://www.ncbi.nlm.nih.gov/pubmed/32180953
http://dx.doi.org/10.1002/fsn3.1426
_version_ 1783504694963863552
author Vo, Trung Duc
Sulaiman, Christina
Tafazoli, Shahrzad
Lynch, Barry
Roberts, Ashley
Chikamatsu, Go
author_facet Vo, Trung Duc
Sulaiman, Christina
Tafazoli, Shahrzad
Lynch, Barry
Roberts, Ashley
Chikamatsu, Go
author_sort Vo, Trung Duc
collection PubMed
description Glutaminase (glutamine aminohydrolase EC 3.5.1.2) is used in the production of food ingredients rich in l‐glutamic acid that are added to finished foods for the purpose of enhancing or improving the savory flavor profile of food. The glutaminase enzyme preparation evaluated in these studies, designated as Sumizyme GT hereafter, is obtained by fermentation of Aspergillus niger strain GT147. The safety of Sumizyme GT was evaluated in a series of standard toxicological studies, including a 90‐day oral toxicity study in rats, an in vitro bacterial reverse mutation assay, an in vitro mammalian chromosome aberration test, and an in vivo alkaline Comet assay. Sumizyme GT was not mutagenic or genotoxic, and administration of the enzyme by gavage at doses up to 2,570 mg total organic solids (TOS)/kg body weight (bw) per day for 90 days was without any systemic toxicity. The no‐observed‐adverse‐effect level was concluded to be 2,570 mg TOS/kg bw per day, the highest dose tested. Considering that A. niger has an established history of safe use in the food industry and its safety in the production of food ingredients and food enzymes is well documented, the results of these studies provide further support of the safety of glutaminase from A. niger when used in food production.
format Online
Article
Text
id pubmed-7063383
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70633832020-03-16 Safety assessment of glutaminase from Aspergillus niger Vo, Trung Duc Sulaiman, Christina Tafazoli, Shahrzad Lynch, Barry Roberts, Ashley Chikamatsu, Go Food Sci Nutr Original Research Glutaminase (glutamine aminohydrolase EC 3.5.1.2) is used in the production of food ingredients rich in l‐glutamic acid that are added to finished foods for the purpose of enhancing or improving the savory flavor profile of food. The glutaminase enzyme preparation evaluated in these studies, designated as Sumizyme GT hereafter, is obtained by fermentation of Aspergillus niger strain GT147. The safety of Sumizyme GT was evaluated in a series of standard toxicological studies, including a 90‐day oral toxicity study in rats, an in vitro bacterial reverse mutation assay, an in vitro mammalian chromosome aberration test, and an in vivo alkaline Comet assay. Sumizyme GT was not mutagenic or genotoxic, and administration of the enzyme by gavage at doses up to 2,570 mg total organic solids (TOS)/kg body weight (bw) per day for 90 days was without any systemic toxicity. The no‐observed‐adverse‐effect level was concluded to be 2,570 mg TOS/kg bw per day, the highest dose tested. Considering that A. niger has an established history of safe use in the food industry and its safety in the production of food ingredients and food enzymes is well documented, the results of these studies provide further support of the safety of glutaminase from A. niger when used in food production. John Wiley and Sons Inc. 2020-02-18 /pmc/articles/PMC7063383/ /pubmed/32180953 http://dx.doi.org/10.1002/fsn3.1426 Text en © 2020 The Authors. Food Science & Nutrition published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Vo, Trung Duc
Sulaiman, Christina
Tafazoli, Shahrzad
Lynch, Barry
Roberts, Ashley
Chikamatsu, Go
Safety assessment of glutaminase from Aspergillus niger
title Safety assessment of glutaminase from Aspergillus niger
title_full Safety assessment of glutaminase from Aspergillus niger
title_fullStr Safety assessment of glutaminase from Aspergillus niger
title_full_unstemmed Safety assessment of glutaminase from Aspergillus niger
title_short Safety assessment of glutaminase from Aspergillus niger
title_sort safety assessment of glutaminase from aspergillus niger
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7063383/
https://www.ncbi.nlm.nih.gov/pubmed/32180953
http://dx.doi.org/10.1002/fsn3.1426
work_keys_str_mv AT votrungduc safetyassessmentofglutaminasefromaspergillusniger
AT sulaimanchristina safetyassessmentofglutaminasefromaspergillusniger
AT tafazolishahrzad safetyassessmentofglutaminasefromaspergillusniger
AT lynchbarry safetyassessmentofglutaminasefromaspergillusniger
AT robertsashley safetyassessmentofglutaminasefromaspergillusniger
AT chikamatsugo safetyassessmentofglutaminasefromaspergillusniger